Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha L Durfey

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JCI Insight|December 22, 2021
A population-level strain genotyping method to study pathogen strain dynamics in human infectionsSarah J Morgan, Samantha L Durfey, Sumedha Ravishankar, et al.
Frontiers in Immunology|February 12, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosisHazel Ozuna, Dinesh Bojja, Santiago Partida-Sanchez, et al.
The Journal of Clinical Investigation|June 24, 2021
Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulatorsTayyab Rehman, Philip H Karp, Ping Tan, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JCI Insight|December 22, 2021
A population-level strain genotyping method to study pathogen strain dynamics in human infectionsSarah J Morgan, Samantha L Durfey, Sumedha Ravishankar, et al.
Frontiers in Immunology|February 12, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosisHazel Ozuna, Dinesh Bojja, Santiago Partida-Sanchez, et al.
The Journal of Clinical Investigation|June 24, 2021
Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulatorsTayyab Rehman, Philip H Karp, Ping Tan, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
Cell Host & Microbe|August 6, 2025
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationSamantha L Durfey, Siddhartha G Kapnadak, Tahuanty Pena, et al.
Pageof 1